30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Vicki Sato

Track

Insider profile

Currently holds positions in Denali Therapeutics Inc, Vir Biotechnology Inc, BorgWarner Inc and Bristol-Myers Squibb Co

Positions

Position Company Period
Independent Chairman of the Board Denali Therapeutics Inc Aug. 1, 2016 -
Independent Chairman of the Board Vir Biotechnology Inc Dec. 1, 2016 -
Independent Director BorgWarner Inc Feb. 12, 2014 -
Lead Independent Director Bristol-Myers Squibb Co Jan. 1, 2017 -
Independent Director Syros Pharmaceuticals Inc Aug. 1, 2013 - Dec. 19, 2019
Independent Director Revvity Inc Oct. 18, 2001 - April 25, 2017
Independent Director Bristol-Myers Squibb Co July 11, 2006 - Jan. 1, 2017
Independent Director Denali Therapeutics Inc April 1, 2015 - Aug. 1, 2016
Non-Executive Independent Director Galapagos NV April 26, 2011 - Dec. 31, 2014
Vicki Sato's trades of Vir Biotechnology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-04 2026-05-01
PlS Planned sale
82,411 -49.6%
454.43
US$1,181,669 		82,411 -49.6% 454.43 US$1,181,669
2026-04-02 2026-04-01
PlS Planned sale
40,815 +25.6%
183.48
US$870,621 		40,815 +25.6% 183.48 US$870,621
2026-03-03 2026-03-02
PlS Planned sale
15,230 +35.4%
388.89
US$4,743,364 		15,230 +35.4% 388.89 US$4,743,364
2026-03-03 2026-03-02
PlS Planned sale
21,800 -1.9%
9.50
US$207,185 		21,800 -1.9% 9.50 US$207,185
2026-03-02 2026-03-02
PrS Proposed sale
88,000
9.09
US$799,920 		88,000 9.09 US$799,920
2026-02-26 2026-02-24
PlS Planned sale
200 -0.0%
10.26
US$2,052 		200 -0.0% 10.26 US$2,052
2026-02-26 2026-02-24
PlS Planned sale
42,177 -3.6%
9.75
US$411,314 		42,177 -3.6% 9.75 US$411,314
2026-02-24 2026-02-24
PrS Proposed sale
20,377
7.43
US$151,401 		20,377 7.43 US$151,401
2026-02-03 2026-02-02
PlS Planned sale
22,000 -1.9%
7.71
US$169,671 		22,000 -1.9% 7.71 US$169,671
2026-01-05 2026-01-02
PlS Planned sale
22,000 -1.9%
5.93
US$130,383 		22,000 -1.9% 5.93 US$130,383
2026-01-02 2026-01-02
PrS Proposed sale
66,000
6.03
US$397,980 		66,000 6.03 US$397,980
2025-12-02 2025-12-01
PlS Planned sale
22,000 -1.8%
6.00
US$132,070 		22,000 -1.8% 6.00 US$132,070
2025-11-04 2025-11-03
PlS Planned sale
22,000 -1.8%
5.64
US$124,047 		22,000 -1.8% 5.64 US$124,047
2025-10-02 2025-10-01
PlS Planned sale
22,000 -1.8%
5.84
US$128,396 		22,000 -1.8% 5.84 US$128,396
2025-10-01 2025-10-01
PrS Proposed sale
66,000
5.71
US$376,860 		66,000 5.71 US$376,860
2025-09-03 2025-09-02
PlS Planned sale
22,000 -1.7%
4.99
US$109,811 		22,000 -1.7% 4.99 US$109,811
2025-08-04 2025-08-01
PlS Planned sale
22,000 -1.7%
4.99
US$109,699 		22,000 -1.7% 4.99 US$109,699
2025-07-02 2025-07-01
PlS Planned sale
22,000 -1.7%
5.10
US$112,207 		22,000 -1.7% 5.10 US$112,207
2025-07-01 2025-07-01
PrS Proposed sale
66,000
5.04
US$332,640 		66,000 5.04 US$332,640
2025-01-08 2025-01-08
PrS Proposed sale
43,840
7.89
US$345,898 		43,840 7.89 US$345,898
2025-01-08 2025-01-08
PlS Planned sale
10,960 -0.8%
12.52
US$137,219 		10,960 -0.8% 12.52 US$137,219
2025-01-03 2025-01-02
PlS Planned sale
3,080 -2.8%
20.91
US$64,403 		3,080 -2.8% 20.91 US$64,403
2025-01-02 2025-01-02
PrS Proposed sale
6,160
20.38
US$125,541 		6,160 20.38 US$125,541
2024-11-12 2024-11-07
PlS Planned sale
1,020 -0.9%
30.00
US$30,600 		1,020 -0.9% 30.00 US$30,600
2024-11-05 2024-11-01
PlS Planned sale
3,080 -2.7%
27.07
US$83,376 		3,080 -2.7% 27.07 US$83,376
2024-09-16 2024-09-13
PlS Planned sale
1,020 -0.9%
30.00
US$30,600 		1,020 -0.9% 30.00 US$30,600
2024-09-13 2024-09-13
PrS Proposed sale
6,160
27.96
US$172,234 		6,160 27.96 US$172,234
2024-09-04 2024-09-03
PlS Planned sale
100 -0.1%
25.37
US$2,537 		100 -0.1% 25.37 US$2,537
2024-09-04 2024-09-03
PlS Planned sale
2,980 -2.5%
24.99
US$74,470 		2,980 -2.5% 24.99 US$74,470
2024-07-03 2024-07-01
PlS Planned sale
100 -0.1%
22.86
US$2,286 		100 -0.1% 22.86 US$2,286
2024-07-03 2024-07-01
PlS Planned sale
2,980 -2.4%
22.12
US$65,918 		2,980 -2.4% 22.12 US$65,918
2024-07-01 2024-07-01
PrS Proposed sale
6,160
23.22
US$143,035 		6,160 23.22 US$143,035
2024-05-17 2024-05-15
PlS Planned sale
1,674 -1.4%
20.39
US$34,133 		1,674 -1.4% 20.39 US$34,133
2024-04-17 2024-04-15
PlS Planned sale
1,666 -1.4%
18.29
US$30,471 		1,666 -1.4% 18.29 US$30,471
2024-04-15 2024-04-15
PrS Proposed sale
3,340
18.26
US$60,988 		3,340 18.26 US$60,988
2024-03-19 2024-03-15
PlS Planned sale
1,666 -1.4%
20.10
US$33,487 		1,666 -1.4% 20.10 US$33,487
2024-02-20 2024-02-15
PlS Planned sale
1,666 -1.4%
18.37
US$30,604 		1,666 -1.4% 18.37 US$30,604
2024-01-18 2024-01-16
PlS Planned sale
1,666 -1.3%
18.42
US$30,688 		1,666 -1.3% 18.42 US$30,688
2024-01-16 2024-01-16
PrS Proposed sale
4,998
18.54
US$92,663 		4,998 18.54 US$92,663
2023-12-18 2023-12-15
PlS Planned sale
1,666 -1.3%
23.39
US$38,968 		1,666 -1.3% 23.39 US$38,968
2023-11-16 2023-11-15
PlS Planned sale
1,666 -1.3%
19.13
US$31,871 		1,666 -1.3% 19.13 US$31,871
2023-10-18 2023-10-16
PlS Planned sale
1,666 -1.3%
20.66
US$34,420 		1,666 -1.3% 20.66 US$34,420
2023-10-16 2023-10-16
PrS Proposed sale
4,998
20.76
US$103,758 		4,998 20.76 US$103,758
2023-09-19 2023-09-15
PlS Planned sale
40 -0.0%
24.35
US$974 		40 -0.0% 24.35 US$974
2023-09-19 2023-09-15
PlS Planned sale
1,626 -1.2%
23.60
US$38,374 		1,626 -1.2% 23.60 US$38,374